STAT '3 to Watch' series looks at biotech industry issues in 2025: Trump administration uncertainties, pharma deals in China, ...

CRISPR Therapeutics' approved medicine could benefit from government coverage in the U.S. This is a good sign for the biotech ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

Sheel Biotech offers cutting-edge technologies like tissue culture, hydroponics, and high-tech greenhouses to enhance farming ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains ...

The Federal Reserve rolled out its third interest rate cut of 2024 yesterday, a move expected to lower borrowing costs across ...

We recently compiled a list of the 10 Best Performing Biotech Stocks in 2024. In this article, we are going to take a look at ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Fierce Biotech is taking the opportunity to reflect on trends emerging from 2024’s reporting. | For the end of this year, ...

The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace of news ...

Legend Biotech ( (LEGN) ) just unveiled an update.